Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum.
Feizpour A, Doré V, Doecke JD, Saad ZS, Triana-Baltzer G, Slemmon R, Maruff P, Krishnadas N, Bourgeat P, Huang K, Fowler C, Rainey-Smith SR, Bush AI, Ward L, Robertson J, Martins RN, Masters CL, Villemagne VL, Fripp J, Kolb HC, Rowe CC.
Feizpour A, et al. Among authors: huang k.
J Prev Alzheimers Dis. 2023;10(4):828-836. doi: 10.14283/jpad.2023.83.
J Prev Alzheimers Dis. 2023.
PMID: 37874105